Rapid diagnostic tests are not reliable The Serology Task Force of the National Coordination Centre for Testing Capacity – a partnership between RIVM, hospitals and laboratories – has collected research results on rapid diagnostic tests
Rapid and accurate contact tracing required in the coming period Now that the Cabinet is relaxing the measures to combat the novel coronavirus step by step, people will go outside more frequently. The chance of the virus spreading again will then increase.
Clear impact achieved by national measures to combat the COVID-19 epidemic To monitor the effect of the measures against the spread of the novel coronavirus, the time when reported COVID-19 patients became ill was examined.
Sustainable procurement benefits people and the environment RIVM has developed a method to calculate the effects of Sustainable Procurement and applied the method to eight product groups: energy, gas, solar panels, company cars, business trips, workwea
First products Dutch Public Health Foresight study available in English In 2017, RIVM launched a Trend Scenario, as well as three thematic reports about the future demand for health care, technology and wider determinants of health.
Smart lotteries promote physical activity Commitment lotteries can support overweight adults in their goal to exercise on a regular basis.That is the conclusion of a scientific study by Tilburg University, High Five Health Promotion and RI
Climate Resilient Water Safety Plans Workshop Mozambique RIVM and the Institute for Water Education (IHE) Delft facilitated a workshop on Climate Resilient Water Safety Plans (CR-WSP) on January 22 - 23 2018, in Maputo, Mozambique.
Chance of ESBL contamination via livestock farming is small ESBL is an enzyme, produced by certain bacteria, which makes these bacteria resistant to antibiotics.
RIVM publications score above average worldwide A new bibliometric analysis method of the University of Leiden shows that the publications of the Strategic Programme of RIVM (SPR) score well worldwide.
New test has no added value in Lyme disease of the central nervous system Active Lyme disease of the central nervous system cannot be detected with an ELISpot test.